The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
Open accessAbstract
Despite significant progress in the treatment of breast cancer, particularly through the use of targeted therapy, relapse and chemoresistance remain a major hindrance to the fight to minimize the burden of the disease. It is becoming increasingly clear that a rare subpopulation of cells known as cancer stem cells (CSC), able to be generated through epithelial-to-mesenchymal transition (EMT) and capable of tumor initiation and self-renewal, contributes to treatment resistance and metastases. This means that a more effective therapy should target both the chemoresistant CSCs and the proliferating epithelial cells that give rise to them to reverse EMT and to attenuate their conversion to CSCs. Here, we demonstrate a novel function of AXL in acting upstream to induce EMT in normal and immortalized human mammary epithelial cells in an apparent positive feedback loop mechanism and regulate breast CSC (BCSC) self-renewal and chemoresistance. Downregulation of AXL using MP470 (Amuvatinib) reversed EMT in mesenchymal normal human mammary epithelial cells and murine BCSCs attenuating self-renewal and restored chemosensitivity of the BCSCs. AXL expression was also found to be associated with the expression of stem cell genes, regulation of metastases genes, increased tumorigenicity and was important for BCSC invasion and migration. Inactivation of AXL also led to the downregulation of nuclear factor-κB pathway and reduced tumor formation in vivo. Taken together, our data suggest that targeted therapy against AXL, in combination with systemic therapies, has the potential to improve response to anticancer therapies and to reduce breast cancer recurrence and metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Morel, A.-P., Lièvre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002888 · Cited by 1,645
Cancer stem cells: mirage or reality?
Gupta, P. B., Chaffer, C. L., & Weinberg, R. A. (2009) · Nature Medicine · doi:10.1038/nm0909-1010 · Cited by 979
O'Bryan, J. P., Frye, R. A., Cogswell, P. C., Neubauer, A., Kitch, B., Prokop, C., Espinosa, R., Le Beau, M. M., Earp, H. S., & Liu, E. T. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.5016 · Cited by 742
Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.-P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J. B., & Ivaska, J. (2011) · Oncogene · doi:10.1038/onc.2010.509 · Cited by 647
Gjerdrum, C., Tiron, C., Høiby, T., Stefansson, I., Haugen, H., Sandal, T., Collett, K., Li, S., McCormack, E., Gjertsen, B. T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909333107 · Cited by 594
Holland, S. J., Pan, A., Franci, C., Hu, Y., Chang, B., Li, W., Duan, M., Torneros, A., Yu, J., Heckrodt, T. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2997 · Cited by 550
Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL
Liu, L., Greger, J., Shi, H., Liu, Y., Greshock, J., Annan, R., Halsey, W., Sathe, G. M., Martin, A.-M., & Gilmer, T. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4490 · Cited by 495
Epithelial-mesenchymal transition
Radisky, D. C. (2005) · Journal of Cell Science · doi:10.1242/jcs.02552 · Cited by 417
Self-citationImmune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells
Santisteban, M., Reiman, J. M., Asiedu, M. K., Behrens, M. D., Nassar, A., Kalli, K. R., Haluska, P., Ingle, J. N., Hartmann, L. C., Manjili, M. H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3343 · Cited by 379
Self-citationGas6 and protein S: Vitamin K‐dependent ligands for the Axl receptor tyrosine kinase subfamily
Hafizi, S., & Dahlbäck, B. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05529.x · Cited by 355
Cancer stem cells – old concepts, new insights
Vermeulen, L., Sprick, M. R., Kemper, K., Stassi, G., & Medema, J. P. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.20 · Cited by 352
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells
Grimshaw, M. J., Cooper, L., Papazisis, K., Coleman, J. A., Bohnenkamp, H. R., Chiapero-Stanke, L., Taylor-Papadimitriou, J., & Burchell, J. M. (2008) · Breast Cancer Research · doi:10.1186/bcr2106 · Cited by 339
Blick, T., Hugo, H., Widodo, E., Waltham, M., Pinto, C., Mani, S. A., Weinberg, R. A., Neve, R. M., Lenburg, M. E., & Thompson, E. W. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9175-z · Cited by 292
Li, Y., Ye, X., Tan, C., Hongo, J. A., Zha, J., Liu, J., Kallop, D., Ludlam, M. J. C., & Pei, L. (2009) · Oncogene · doi:10.1038/onc.2009.212 · Cited by 288
Hutterer, M., Knyazev, P., Abate, A., Reschke, M., Maier, H., Stefanova, N., Knyazeva, T., Barbieri, V., Reindl, M., Muigg, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0862 · Cited by 280
Expression of Axl in Lung Adenocarcinoma and Correlation with Tumor Progression
Shinh, Y.-S., Lai, C.-Y., Kao, Y.-R., Shiah, S.-G., Chu, Y.-W., Lee, H.-S., & Wu, C.-W. (2005) · Neoplasia · doi:10.1593/neo.05640 · Cited by 273
Asiedu, M. K., Ingle, J. N., Behrens, M. D., Radisky, D. C., & Knutson, K. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4554 · Cited by 270
Self-citationVajkoczy, P., Knyazev, P., Kunkel, A., Capelle, H.-H., Behrndt, S., von Tengg-Kobligk, H., Kiessling, F., Eichelsbacher, U., Essig, M., Read, T.-A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510923103 · Cited by 242
NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target
Chen, W. (2011) · Frontiers in Bioscience · doi:10.2741/3782 · Cited by 233
The cancer stem cell hypothesis: in search of definitions, markers, and relevance
Shipitsin, M., & Polyak, K. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.14 · Cited by 231
AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
Rankin, E. B., Fuh, K. C., Taylor, T. E., Krieg, A. J., Musser, M., Yuan, J., Wei, K., Kuo, C. J., Longacre, T. A., & Giaccia, A. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1267 · Cited by 229
Phosphoproteomic analysis of Her2/neu signaling and inhibition
Bose, R., Molina, H., Patterson, A. S., Bitok, J. K., Periaswamy, B., Bader, J. S., Pandey, A., & Cole, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603948103 · Cited by 215
AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression
Zhang, Y.-X., Knyazev, P. G., Cheburkin, Y. V., Sharma, K., Knyazev, Y. P., Őrfi, L., Szabadkai, I., Daub, H., Kéri, G., & Ullrich, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2661 · Cited by 210
Koorstra, J.-B. M., Karikari, C., Feldmann, G., Bisht, S., Leal-Rojas, P., Offerhaus, G. J. A., Alvarez, H., & Maitra, A. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.7.7923 · Cited by 205
Akt Is a Downstream Target of NF-κB
Meng, F., Liu, L., Chin, P. C., & D'Mello, S. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112464200 · Cited by 193
Cancer Stem Cells and Metastasis: Lethal Seeds
Wicha, M. S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1537 · Cited by 174
Song, X., Wang, H., Logsdon, C. D., Rashid, A., Fleming, J. B., Abbruzzese, J. L., Gomez, H. F., Evans, D. B., & Wang, H. (2010) · Cancer · doi:10.1002/cncr.25483 · Cited by 174
Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1
Tai, K.-Y., Shieh, Y.-S., Lee, C.-S., Shiah, S.-G., & Wu, C.-W. (2008) · Oncogene · doi:10.1038/onc.2008.57 · Cited by 168
Keating, A. K., Kim, G. K., Jones, A. E., Donson, A. M., Ware, K. E., Mulcahy, J. M., Salzberg, D. B., Foreman, N. K., Liang, X., Thorburn, A. M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0707 · Cited by 150
Receptor tyrosine kinases expressed in metastatic colon cancer
Craven, R. J., Xu, L., Weiner, T. M., Fridell, Y.-W. C., Dent, G. A., Srivastava, S., Varnum, B. C., Liu, E. T., & Cance, W. G. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600611 · Cited by 146
Cancer Stem Cells: A New Paradigm for Understanding Tumor Growth and Progression and Drug Resistance
Gangemi, R. M. R., Paleari, L., Orengo, A. M., Cesario, A., Chessa, L., Ferrini, S., & Russo, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788186147 · Cited by 129
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
Welsh, J. W., Mahadevan, D., Ellsworth, R., Cooke, L. S., Bearss, D. J., & Stea, B. (2009) · Radiation Oncology · doi:10.1186/1748-717x-4-69 · Cited by 104
Expression of the Receptor Tyrosine Kinase Axl Promotes Ocular Melanoma Cell Survival
van Ginkel, P. R., Gee, R. L., Shearer, R. L., Subramanian, L., Walker, T. M., Albert, D. M., Meisner, L. F., Varnum, B. C., & Polans, A. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0245 · Cited by 96
Expression of the Proto-Oncogene Axl in Renal Cell Carcinoma
Chung, B. I., Malkowicz, S. B., Nguyen, T. B., Libertino, J. A., & McGarvey, T. W. (2003) · DNA and Cell Biology · doi:10.1089/10445490360708946 · Cited by 82
Axl-Gas6 Interaction Counteracts E1A-Mediated Cell Growth Suppression and Proapoptotic Activity
Lee, W.-P., Liao, Y., Robinson, D. R., Kung, H.-J., Liu, E. T., & Hung, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8075 · Cited by 64
Tumor initiating cancer stem cells from human breast cancer cell lines
Crowe (2009) · International Journal of Oncology · doi:10.3892/ijo_00000273 · Cited by 41
Cowin, P., & Welch, D. R. (2007) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-007-9041-9 · Cited by 40
The evolution of cancer modeling: the shadow of stem cells
Vicente‐Dueñas, C., Cobaleda, C., Pérez‐Losada, J., & Sánchez-García, I. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.002774 · Cited by 15
Cited by
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Graham, D. K., DeRyckere, D., Davies, K. D., & Earp, H. S. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3847 · Cited by 698
Lim, Z.-F., & Ma, P. C. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0818-2 · Cited by 630
Zhu, C., Wei, Y., & Wei, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1090-3 · Cited by 488
Immune Checkpoint Inhibitors: Basics and Challenges
Li, B., Chan, H. L., & Chen, P. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170804143706 · Cited by 480
Drugging the efferocytosis process: concepts and opportunities
Mehrotra, P., & Ravichandran, K. S. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00470-y · Cited by 459
Metadata
- Authors
- Asiedu, M. K., Beauchamp-Perez, F. D., Ingle, J. N., Behrens, M. D., Radisky, D. C., & Knutson, K. L.
- Venue
- Oncogene
- Published
- 2013-03-11
- Volume
- 33
- Issue
- 10
- Pages
- 1316-1324
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2149542744
- Cited by
- 303
- References
- 45
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.